Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 19 12 2018
revised: 04 03 2019
accepted: 11 03 2019
pubmed: 29 4 2019
medline: 23 11 2019
entrez: 29 4 2019
Statut: ppublish

Résumé

In 2017, the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing approved the use of iron-depleted cation-adjusted Mueller-Hinton broth (ID-CAMHB) prepared with Chelex® 100 resin (Bio-Rad Laboratories, Hercules, CA) to determine MICs for cefiderocol. The current study examined the reproducibility of cefiderocol MICs generated for 19 clinical isolates of Gram-negative bacilli, with CAMHB produced by three manufacturers; each of the 19 isolates was tested for 10 replicates in ID-CAMHB from each manufacturer. When analyzed by individual media lot, greater than 95% of MIC results were within ± one doubling-dilution of the mode for each of the 19 isolates tested. The remaining 5.0% of MIC results were within ± two doubling-dilutions of the modal MIC. For all media lots combined, 92.2% of MIC results were within ± one doubling-dilution of the modal MIC for each isolate, 99.8% were within ± two doubling-dilutions and 100% were within three doubling-dilutions.

Identifiants

pubmed: 31029489
pii: S0732-8893(18)30788-0
doi: 10.1016/j.diagmicrobio.2019.03.003
pii:
doi:

Substances chimiques

Cations, Divalent 0
Cephalosporins 0
Culture Media 0
Siderophores 0
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-325

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Meredith A Hackel (MA)

International Health Management Associates, Inc., Schaumburg, IL, USA. Electronic address: mhackel@ihmainc.com.

Masakatsu Tsuji (M)

Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., Osaka, Japan.

Yoshinori Yamano (Y)

Pharmaceutical Research Division, Shionogi & Co., Ltd., Osaka, Japan.

Roger Echols (R)

Clinical Development and Medical Affairs, ID3C, LLC, Easton, CT, USA.

James A Karlowsky (JA)

Department of Medical Microbiology and Infectious Diseases, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Daniel F Sahm (DF)

International Health Management Associates, Inc., Schaumburg, IL, USA.

Articles similaires

Aspergillus Hydrogen-Ion Concentration Coculture Techniques Secondary Metabolism Streptomyces rimosus
Humans Middle Aged Female Male Surveys and Questionnaires
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH